怪物饮料 MNST 深 沪
等待开盘 07-08 09:30:00 美东时间
96.92
-0.450
-0.46%
华盛通- 最 高99.1499
- 今 开98.41
- 成交量 849.31万股
- 最 低 95.705
- 昨 收 97.37
- 总市值 9478.85万
- 52周最高 99.1499
- 市盈率 静 50.07
- 换手率 0.87%
- 52周最低 58.09
- 委 比 89.42%
- 总股本 0.01亿
- 历史最高 99.1499
- 量 比 1.62
- 振 幅 3.54%
- 历史最低 5.7383
- 每 手 1
- 风险率 9.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MLB概念股票盘中上涨 DraftKings涨5.9% 捷蓝航空涨3.6% Monster Beverage涨3.6%
美国职业棒球大联盟相关概念股盘中走高。 DraftKings股价上涨5.9% 捷蓝航空（JetBlue Airways）涨幅达3.6% Monster饮料（...
06-27 02:40
Here's How Much $100 Invested In Monster Beverage 15 Years Ago Would Be Worth Today
Monster Beverage (NASDAQ:MNST) has outperformed the market over the past 15 years by 6.81% on an annualized basis producing an average annual return of 19.19%. Currently, Monster Beverage has a market capitalization of $91.00 billion. Buying $100 In MNST: If an investor had bought $100 of MNST stock...
06-23 00:00
Oppenheimer’s top buy ideas and sell ideas within each sector
Oppenheimer analysts remain constructive on the market rally, identifying beta and momentum as the two primary drivers of the advance off the March low. While critics often cite the risk of a momentum...
06-15 23:39
Stock index futures surge buoyed by U.S.-Iran peace deal
Stock index futures were sharply higher on Monday as the U.S. and Iran announced a long-awaited peace agreement that would restore shipping through the Strait of Hormuz. Nasdaq 100 futures (US100:IND)...
06-15 16:10
美股大行评级 | Adobe惨遭18家大行下调目标价！CFRA首予SpaceX(SPCX)"卖出"评级，目标价115美元
今日重点评级关注：Piper Sandler：维持Tenax Therapeutics"超配"评级，目标价从20美元升至50美元；Tigress Financial：维持优步"买入"评级，目标价从110美元升至115美元
06-15 08:32
Bernstein Initiates Coverage On Monster Beverage with Market Perform Rating, Announces Price Target of $95
Bernstein analyst Cristian Rios initiates coverage on Monster Beverage (NASDAQ:MNST) with a Market Perform rating and announces Price Target of $95.
06-12 22:53
怪物饮料的国际市场繁荣：海外销售额为何达45%
怪兽饮料公司（Monster Beverage Corporation）MNST 2026年第一季度国际业务表现出色，欧洲、亚太和拉丁美洲需求强劲，海外业务营收...
06-04 01:38
美股大行评级 | 瑞杰金融上调美光目标价从530美元升至1100美元；AMD、Arm、戴尔、英特尔等获多家机构上调目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13.5美元升至14美元；BTIG：维持Jade Biosciences"买入"评级，目标价从39美元升至74美元
06-02 16:25
